Professor Samra Turajlic BA MBBS MRCP PhD
Professor Samra Turajlic completed her undergraduate studies at Oxford University and her clinical training at UCL medical school.
She gained a PhD in 2013 from University of London (ICR) in the field of melanoma genetics and targeted therapy resistance.
In 2014 she was awarded a Cancer Research UK Clinician Scientist Fellowship to study cancer evolution at the Francis Crick Institute (FCI). She completed her training in medical oncology in 2015 and joined the Skin and Urology Units at the Royal Marsden Hospital as a Consultant Medical Oncologist.
She became an independent Group Leader at the Francis Crick Institute in 2019, and divides her time between the clinic and her lab. Professor Turajlic is the Chief Investigator of translational studies into melanoma and kidney cancer. Her main research goal is to improve our understanding of the biology of kidney cancer and melanoma and the reasons for treatment success and failure. Her clinical research interest is in validating novel targets and therapies for these diseases.
She is a European Society of Medical Oncology (ESMO) Faculty member for genitourinary cancers, and Scientific Committee member for ESMO, Molecular Analysis for Personalised Therapy, Kidney Cancer Association, and EORTC-NCI-AACR Symposia. She is also a Trustee of Melanoma Focus, as well as a Senior Editor at Macmillan Cancer Support.